Found: 38
ОБЗОР2018
Shikh E.V., Volodin A.A., Maksimov M.L., Tarasov V.V.
Diabetes mellitus (DM) is a dangerous challenge to the entire international community and the priority of the first order national health systems of all countries over the world. The growing level of hyperglycemia in type 2 diabetes is associated with the incr…
ПЕРЕДОВАЯ СТАТЬЯ2018
Paltsev M.A., Zuev V.A., Diatlova A.S., Linkova N.S., Kvetnaia T.V.
Parkinson’s disease (PD) is a progressive, age-related, neuronal disorder that affects as much as 1% of the persons over 65 years. According to forecasts of the World Health Organization over the world about 9 million people will suffer from PD by 2030. So PD …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2017
Mikhailova G.F., Tsepenko V.V., Skoropad V.Yu., Rukhadze G.О., Shkavrova T.G., Golub Е.V.
Introduction. Recent reports have demonstrated patients with malignant neoplasias have different molecular genetic aberrations. But there are few data available concerning patients with multiple primary tumors (MPT). Aim. To study molecular genetic alterations…
ОБЗОР2016
Korshunov D.A., Korshunova Z.V., Kondakova I.V.
Energy supply of cells can be provided through both an oxygen-dependent pathway of mitochondrial oxidative phosphorylation and oxygenindependent glycolysis. Oxidative phosphorylation in the synthesis of ATP is more efficient than in glycolysis, and respectivel…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016
Kit O.I., Vodolazhsky D.I., Maksimov A.Yu., Lazutin Yu.N., Pyltsin S.P., Leyman I.A., Makueva A.M.
Introduction. EGFR mutation and EML4-ALK fusion are the most clinically significant genetic alterations in non-small cell lung cancer. Numerous studies have been devoted to EGFR mutations and their association with phenotypic clinical and pathological characte…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016
Kushlinskii N. E., Gershtein E. S., Timofeev Yu. S., Korotkova E. A., Babkina I.V., Zuev A.A., Soloviev Yu.N.
Introduction. RANK/RANKL/OPG ligand-receptor system is a key player in bone tissue homeostasis directly regulating osteoclast differentiation and osteolysis. Many pathologic processes imposed by impairments in bone remodeling including tumor growth and metasta…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016
Kryzhanovskii S.A., Ionova E.O., Stolyaruk V.N., Tsorin I.B., Vititnova M.B.
The purpose of research. The study of the features of the left ventricle remodeling in the acutest stage of experimental myocardial infarction and the possibility of the correction of detected injuries. Methods. Experimental myocardial infarction in rats was i…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Korotaeva A.A, Karpukhin A.V.
Genes encoding proteins of IAP (Inhibitor of apoptosis proteins) have increased expression in the cells of malignant tumors of different localizations. IAPs perform several functions related to the viability of cancer cells and their subsequent proliferation. …
ОБЗОР2015
Ustinnikova O.B., Bondarev V.P., Rounova O.B., Novikova E.V., Gorbunova E.V.
The review is devoted to problems of quality assessment of recombinant coagulation factors approved in the Russian Federation. The list of recombinant blood coagulation factor products approved in the world was provided. Benefits of the use of recombinant bloo…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Denisenko N.P., Sychev D.A., Sizova Zh.M., Kazakov R.E., Grachev A.V.
Introduction. Cytochrome P-450 2C19 is the main isoenzyme responsible for the metabolism of proton pump inhibitors, the main group of drugs for treating stomach and duodenal ulcer. There are genetic differences that affect the activity of this enzyme: there ar…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Alexeev А.А., Brylev M.I., Korolev V.L., Lotorev D.S., Lizunov A.Yu., Zaitseva N.I., Pavlova L.А., Ivshin V.P.
Introduction. Cardiovascular diseases consistently occupy the first place among causes of death and disability in almost all developed countries. The main importance of this group of diseases have myocardial infarction. One of the causes of myocardial infarcti…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015
Filimonova M.V., Yuzhakov V.V., Shevchenko L.I., Bandurko L.N., Sevankaeva L.E., Makarchuk V.M., Chesnakova E.A., Shevchuk A.S., Tsyganova M.G., Fomina N.K., Ingel I.E., Surinova V.I.
Introduction. Activation of eNOS/sGC/cGMP-pathway is a common link in the development of angiogenic action of the majority of pro-angiogenic factors. In this regard, the chemical inhibition of NOS (Nitric Oxide Synthase) may cause a nonspecific angiostatic eff…
Research article2014
Mazurenko N.N., Kushlinskii N.E.
Lung cancer is one of the most common oncologic diseases in the world and the most frequent cause of the death from malignant neoplasms. Last decade’s studies revealed significant number of molecular events leading to the onset and development of non-small cel…
Research article2014
Kulinich T.M., Boldyrev A.N., Bozhenko V.K.
Introduction. P16INK4a protein plays one of the key role in processes of cell proliferation, its inactivation is noted in a number of tumors of various localization. Restoration of the p16INK4a function in neoplastic cells may promote braking of division of tu…
Research article2014
Shuev G.N., Sychev D.A., Khokhlov A.A., Grachev A.V., Beloshitskaya T.A.
Introduction.SLCO1B1 encodes the organic anion–transporting polypeptide which has been shown to regulate the hepatic uptake of statins. SLCO1B1*5 genetic variant is associated with statin-induced myopathy. The aim of the study. Aim of the study is to research …
Research article2013
Somonova O.V., Madzhuga A.V., Elizarova A.L.
Venous thromboembolism (VTE) is a frequent complication associated with increased mortality in cancer patients. The basic role in pathogenesis of thrombotic complication in cancer patients is played by changes in the hemostatic system caused by the tumor itsel…
Research article2013
Gershtein E.S., Kushlinsky D.N., Adamyan L.V., Tereshkina I.V., Laktionov K.P.
Publications devoted to the role of various representatives of matrix metalloproteinases (MMPs) family and their tissue inhibitors in ovarian cancer in differential diagnostics, prognosis and in the development of new treatment modalities are critically analyz…
Research article2013
Mazurenko N.N., Tsyganova I.V., Gagarin I.M., Chuev I.V., Mochalnikova V.V., Kolomeytseva A.A., Gorbunova V.A.
Last successful results in target therapy of cancer were achieved with different tyrosine kinases inhibitors (TKI). Target therapy of non-small cell lung cancer (NSCLC) with EGFR inhibitors gefitinib and erlotinib is effective only in patients with somatic mut…